Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 13 (8) , 873-879
Abstract
No abstract availableKeywords
Funding Information
- Sardinian Regional Government
This publication has 38 references indexed in Scilit:
- Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: An achievable target?Autoimmunity Reviews, 2013
- Renal involvement in autoimmune connective tissue diseasesBMC Medicine, 2013
- Etanercept-Induced Henoch-Schönlein Purpura in a Patient With Ankylosing SpondylitisJCR: Journal of Clinical Rheumatology, 2013
- Appearance of ANCA – associated vasculitis under Tumor necrosis factor-alpha inhibitors treatmentAmerican Journal of Case Reports, 2013
- Biologics-induced autoimmune diseasesCurrent Opinion in Rheumatology, 2013
- Novel diagnostic approaches and cost–benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: Lessons from the 15th Turin Congress on Immune Pathology and Orphan DiseaseAutoimmunity Reviews, 2012
- Drug-Induced Granulomatous Interstitial Nephritis in a Patient With Ankylosing Spondylitis During Therapy With AdalimumabAmerican Journal of Kidney Diseases, 2010
- Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximabClinical Nephrology, 2008
- C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximabClinical Rheumatology, 2007
- Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritisClinical Nephrology, 2004